|
|
|
|
Bioengineering: Study data from H.K. Gan and co-authors update knowledge of bioengineering
Today's Medical & Research News Bioengineering Study data from H.K.Gan and co-authors update knowledge of bioengineering March 20th, 2010 Printer-Friendly Version City:Heidelberg Country:Australia Bioengineering Biotechnology Chemotherapy Drug Therapy...
|
|
|
OriGene to Build Largest Monoclonal Antibody Collection
OriGene Technologies has raised $16m to build what is described as the largest collection of next-generation monoclonal antibodies, which will cover the majority of the human proteome.The funding will be used to continue to build OriGene's TrueMAB monoclonal...
|
|
|
Morphotek, Inc. - Pharmaceuticals & Healthcare - Deals And Alliances Profile - New Report Published
Morphotek, Inc.- Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary...
|
|
|
OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodi
B(TM)) to Cover the Majority of Human Proteome ROCKVILLE, Md., March 17 /PRNewswire/ -- OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture...
|
|
|
OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majori
ROCKVILLE, Md., March 17 /PRNewswire/ -- OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO.OriGene's...
|
|
|
OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome
Companies mentioned in this article: OriGene Technologies, Inc.ROCKVILLE, Md., March 17 /PRNewswire/ -- OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel,...
|
|
|
Cosmix Sets Sights on Next-Generation mAbs
HAL Technology Used to Circumvent Problems with Monoclonal Development and Delivery Carol Potera click to enlarge Cosmix generates mAbs using its HAL platform.Monoclonal antibodies have revolutionized the treatment of many diseases by targeting...
|
|
|
Cosmix Sets Sights on Next-Generation mAbs
HAL Technology Used to Circumvent Problems with Monoclonal Development and Delivery Carol Potera click to enlarge Cosmix generates mAbs using its HAL platform.Monoclonal antibodies have revolutionized the treatment of many diseases by targeting...
|
|
|
Alzheimer Disease Therapy: Scientists at Uppsala University publish research in Alzheimer disease therapy
Today's Medical & Research News Scientists at Uppsala University publish research in March 13th, 2010 Printer-Friendly Version City:Uppsala Country:Sweden Alzheimer Disease Biotechnology Dementia Immunotherapy Monoclonal Antibodies Neurobiology...
|
|
|
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence
Monoclonal antibodies may be used more effectively in combination.A previous study of intravenous (iv) bolus alemtuzumab plus rituximab in patients with chronic lymphocytic leukemia (CLL) recurrence produced a response rate of 54% after a 4-week...
|
|
|
Lab901 Extends ScreenTape User Base For Rapid, Automated SDS-PAGE; Plans US Launch
Lab901 announced recently a significant extension of the user base for its protein ScreenTape platform for rapid, convenient, automated SDS-PAGE.The company has completed new shipments of ScreenTape systems to ESBATech, Crucell, Symphogen, Bayer Healthcare...
|
|
|
Human Genome Sciences, BioInvent Intl. Enter Into Collaboration To Discover, Develop Therapeutic Monoclonal An
(RTTNews) - Human Genome Sciences, Inc.(HGSI: News ) said it entered into a collaboration with BioInvent International AB to discover, develop and commercialize therapeutic monoclonal antibodies that specifically target antigens discovered by HGS. Specific...
|
|
|
Monoclonal Antibodies to E.coli O157
coli O157 is an enterohemorrhagic food borne pathogen.It causes disease in humans due to the toxins it secretes. The O157 serotype is the most common serotype associated with this disease. The O polysaccharide found on the surface LPS is unique and can...
|
|
|
Anti GFP, Monoclonal Antibodies
Green Fluorescent Protein (GFP) from jellyfish, Aequorea victria, has been used with increasing success as a marker protein for gene expression, intracellular processes and localization ranginf from bacteria to transgenic mice.Wako offers mouse monoclonal...
|
|
|
BioInvent International AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released
Refer to a friend 2010-03-10 19:43:04 - BioInvent International AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com BioInvent International AB - Pharmaceuticals & Healthcare - Deals...
|
|
|
BioInvent International AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market
www.companiesandmarkets.com/Summary-Company-Profile/bioinvent-in ..BioInvent International AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key...
|
|
|
Monoclonal Antibodies: Studies conducted at The Jackson Laboratory on monoclonal antibodies recently published
Today's Medical & Research News Monoclonal Antibodies Studies conducted at The Jackson Laboratory on monoclonal antibodies recently published March 9th, 2010 Printer-Friendly Version City:Bar Harbor State:ME Country:United States Autoimmune Disease...
|
|
|
Antigen Identification and Characterization of Lung Cancer Specific Monoclonal Antibodies Produced by mAb Proteomics
_ Antigen Identification and Characterization of Lung Cancer Specific Monoclonal Antibodies Produced by mAb Proteomics.
|
|
|
Successful Development of Broad Spectrum Human Monoclonal Antibodies Against Major Influenza Viruses (H1N1 and
INCHEON, South Korea, March 9 /PRNewswire/ -- Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including...
|
|
|
Pharmacokinetic and Pharmacodynamic Modeling of an AntiInterleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
Puchalski T et al.Using a stepwise design, PK/PD modeling was used to select the dose levels in this study. Pharmacokinetic and Pharmacodynamic Modeling of an AntiInterleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic...
|
|
|
Naturally Occurring Human Monoclonal Antibodies Neutralize both 1918 and 2009 Pandemic Influenza A (H1N1) Viruses
Krause JC et al.The authors found that human monoclonal antibodies recognized the Sa antigenic site on the head domains of both 1918 and 2009 hemagglutinins, a site that is hypervariable due to immune selection. Naturally Occurring Human Monoclonal...
|
|
|
Adenosine Therapy: Study results from Trescowthick Laboratories in the area of adenosine therapy published
Today's Medical & Research News Adenosine Therapy Study results from Trescowthick Laboratories in the area of adenosine therapy published March 9th, 2010 Printer-Friendly Version Country:Australia Adenosine Therapy Adenosine Anticancer Therapy Biotechnology...
|
|
|
Monoclonal Antibodies: Research on monoclonal antibodies reported by scientists at Karolinska University, Department of Hematology
Today's Medical & Research News Monoclonal Antibodies Research on monoclonal antibodies reported by scientists at Karolinska University, Department of Hematology March 8th, 2010 Printer-Friendly Version City:Stockholm Country:Sweden Biological Therapy...
|
|
|
University of Texas M. D. Anderson Cancer Center: New strategy develops 2 prototype drugs against cancer, retinal diseases
Today's Medical & Research News University of Texas M.Anderson Cancer Center New strategy develops 2 prototype drugs against cancer, retinal diseases March 8th, 2010 Printer-Friendly Version Amino Acids Angiogenesis Biotechnology Blindness Cetuximab Drug...
|
|
|
Reports outline monoclonal antibodies study results from Medarex, Inc
According to a study from the United States, 'Isomerization of a monoclonal antibody is one of the common routes of protein degradation.An isomerization in the complementarity-determining region (CDR) was found previously and is investigated in depth in this...
|
